Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET
Clinical trial NCT05722925 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05722925
- Sponsor
- OHSU Knight Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-04
- Primary completion
- 2026-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.